MicroRNA Reverse Transcription Market

MicroRNA are small endogenous RNA that regulates gene-expression post-transcriptionally. MicroRNA are abundantly found in the mammalian types and target approximately 60% of the genes of the human and other mammals. MiRNA reverse transcription are crucial regulators of gene expression and promising candidates for biomarker development. A single miRNA can target hundreds of mRNAs and influence the expression of many genes. Further, miRNA reverse transcription involved in many allergies? diseases including eosinophilic esophagitis, asthma and many others which is likely to increase the demand for MicroRNA Reverse Transcription. Current methodologies used for MicroRNA reverse transcription such as RNA-sequencing, microarrays and quantitative PCR.
MicroRNA Reverse Transcription Market contains market size and forecasts of MicroRNA Reverse Transcription in Global, including the following market information:
Global MicroRNA Reverse Transcription Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global MicroRNA Reverse Transcription market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Instruments Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of MicroRNA Reverse Transcription include Sigma Aldrich Corp., Thermo Fisher Scientific, Agilent Technologies, Illumina, Inc., Bio-Rad Laboratories Inc., System Biosciences LLC, HTG Molecular Diagnostics, Inc., GeneCopoeia, Inc. and New England Biolabs, Inc.. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the MicroRNA Reverse Transcription companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global MicroRNA Reverse Transcription Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global MicroRNA Reverse Transcription Market Segment Percentages, by Type, 2021 (%)
Instruments
Kits & Reagents
Consumables
Global MicroRNA Reverse Transcription Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global MicroRNA Reverse Transcription Market Segment Percentages, by Application, 2021 (%)
Cancer
Kidney Disease
Neurological Disease
Cardiovascular Disease
Others
Global MicroRNA Reverse Transcription Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global MicroRNA Reverse Transcription Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies MicroRNA Reverse Transcription revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies MicroRNA Reverse Transcription revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sigma Aldrich Corp.
Thermo Fisher Scientific
Agilent Technologies
Illumina, Inc.
Bio-Rad Laboratories Inc.
System Biosciences LLC
HTG Molecular Diagnostics, Inc.
GeneCopoeia, Inc.
New England Biolabs, Inc.